ethris.com
Get leads like Ethris — and thousands more
Build targeted lists by tech stack, traffic, and more
Ethris: The Stealthy RNA Powerhouse
63 employees, $50M raised, and a thermostable delivery platform that could change everything
Ethris isn't chasing hype—they're building the infrastructure for the next decade of mRNA medicine. While competitors burn cash on marketing, this German biotech is quietly solving the hardest problem in RNA: delivery.
"Thermostable RNA is the holy grail—and Ethris claims to have found it."
The Technology Edge
Ethris owns two proprietary platforms: SNIM®RNA for synthesis and SNaP LNP® for delivery. The key differentiator is thermostability—most LNPs require deep cold storage, but Ethris claims their system works at higher temperatures. If true, this unlocks global distribution networks that competitors can't touch. The 'multi-route' capability suggests inhalable, injectable, and possibly oral delivery pathways from a single base technology.
The Efficiency Paradox
Here's the signal in their noise: 42% direct traffic and 37% organic search for a biotech with under 2,000 monthly visits. This isn't a company broadcasting to the masses—it's a surgical operation. The traffic profile suggests heavy reliance on partnerships, scientific conferences, and direct industry outreach. Their top keywords ('ethris', 'snim') reveal a small but highly targeted audience. This is classic stealth-mode scaling: build the tech, lock in partners, then go public when the platform is proven.
The team composition tells another story. With senior directors in process development and clinical trial management already in place, Ethris has moved beyond pure R&D. They're building for scale. The presence of an IT Manager on the key people list is interesting—most biotechs at this stage outsource infrastructure. This suggests they're digitizing their operations early, possibly preparing for data-heavy clinical trials or AI-driven optimization.
- Thermostable LNP platform could eliminate cold chain logistics—a $20B+ market inefficiency
- Multi-route delivery (inhalable, injectable) creates multiple shots on goal across indications
- 63 employees with $9.8M revenue implies ~$155K revenue per employee—strong for pre-commercial biotech
- German engineering meets mRNA: precision manufacturing focus from day one
The Verdict: Buy or Build?
Ethris is either the next big mRNA platform or the perfect acquisition target for Big Pharma needing delivery tech
What tech stack does Ethris use?
How much traffic does Ethris get?
Traffic & Engagement
Traffic Sources
Where is Ethris's audience located?
What keywords does Ethris rank for?
5 keywordsHow is Ethris's SEO?
Open Graph Image
https://storage.e.jimdo.com/cdn-cgi/image/quality=85,fit=crop,format=auto,width=1200,height=630/image/534955233/9d1bc701-5c1b-4268-a3f5-7d9081741e31.jpg
Meta Tags
Home | ETHRIS
Delivering the Future of RNA Medicine Today. Ethris pioneers next-generation mRNA therapeutics and vaccines using its proprietary SNIM®RNA and SNaP LNP® platforms. Our thermostable, multi-route LNP delivery system enables precise, versatile delivery for innovative therapies.
H1 Tags
Schema Types
What is Ethris's revenue?
Who works at Ethris?
Loading leads...
What do customers think of Ethris?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Ethris
What is Ethris's Revenue?
What does Ethris do?
How fast is Ethris growing?
What technologies does Ethris use?
Who are Ethris's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Ethris?
Social Profiles
Contact Information
Export ethris.com Data
Download the complete tech stack, analytics, leads, and company data for ethris.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About ethris.com
Delivering the Future of RNA Medicine Today. Ethris pioneers next-generation mRNA therapeutics and vaccines using its proprietary SNIM®RNA and SNaP LNP® platforms. Our thermostable, multi-route LNP delivery system enables precise, versatile delivery for innovative therapies.
Company Overview
ethris.com Social Media
Contact ethris.com
Phone Numbers
Technology Stack
ethris.com uses 4 technologies across their website including Lazy Loading, Twitter Cards, Ant Design, and more.
Performance
Lazy Loading
Web Standards
Twitter Cards
UI Libraries
Ant Design
CSS Frameworks
Tailwind CSS
Traffic & Audience
ethris.com receives approximately 2.0K monthly visitors and ranks #8,146,863 globally. The website has a bounce rate of 49% with visitors viewing an average of 1.7 pages per visit. Users spend an average of 0:38 on the site.
The majority of ethris.com's traffic comes from undefined, .
Frequently Asked Questions
What is ethris.com?
What technologies does ethris.com use?
How do I contact ethris.com?
What are ethris.com's social media accounts?
Is ethris.com hiring?
How popular is ethris.com?
Related Searches
This page provides publicly available information about ethris.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit ethris.com directly at https://ethris.com.